Eloxx Pharmaceuticals Inc (ELOX)
0.81
-0.02
(-1.82%)
USD |
OTCM |
Apr 24, 15:07
Eloxx Pharmaceuticals Cash from Operations (TTM): -17.99M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -17.99M |
| June 30, 2023 | -21.49M |
| March 31, 2023 | -29.17M |
| December 31, 2022 | -31.84M |
| September 30, 2022 | -36.12M |
| June 30, 2022 | -36.76M |
| March 31, 2022 | -36.81M |
| December 31, 2021 | -35.00M |
| September 30, 2021 | -29.74M |
| June 30, 2021 | -27.41M |
| March 31, 2021 | -23.93M |
| December 31, 2020 | -28.17M |
| September 30, 2020 | -32.76M |
| June 30, 2020 | -38.82M |
| March 31, 2020 | -42.13M |
| December 31, 2019 | -39.39M |
| September 30, 2019 | -39.19M |
| June 30, 2019 | -35.97M |
| March 31, 2019 | -34.86M |
| December 31, 2018 | -31.37M |
| September 30, 2018 | -22.88M |
| June 30, 2018 | -15.29M |
| March 31, 2018 | -7.186M |
| September 30, 2017 | -1.927M |
| June 30, 2017 | -1.925M |
| Date | Value |
|---|---|
| March 31, 2017 | -2.131M |
| December 31, 2016 | -2.567M |
| September 30, 2016 | -3.118M |
| June 30, 2016 | -3.676M |
| March 31, 2016 | -5.382M |
| December 31, 2015 | -5.993M |
| September 30, 2015 | -6.538M |
| June 30, 2015 | -7.345M |
| March 31, 2015 | -6.142M |
| December 31, 2014 | -6.248M |
| September 30, 2014 | -6.137M |
| June 30, 2014 | -4.868M |
| March 31, 2014 | -4.596M |
| December 31, 2013 | -4.793M |
| September 30, 2013 | -3.937M |
| June 30, 2013 | -3.903M |
| March 31, 2013 | -4.064M |
| December 31, 2012 | -3.29M |
| September 30, 2012 | -3.932M |
| June 30, 2012 | -4.386M |
| March 31, 2012 | -4.302M |
| December 31, 2011 | -4.612M |
| September 30, 2011 | -4.876M |
| June 30, 2011 | -5.391M |
| March 31, 2011 | -7.009M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-42.13M
Minimum
Mar 2020
-17.99M
Maximum
Sep 2023
-32.37M
Average
-33.88M
Median
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |